Drug Profile
JTT 606
Alternative Names: JTT-606Latest Information Update: 29 Nov 2006
Price :
$50
*
At a glance
- Originator Japan Tobacco
- Class Osteoporosis therapies
- Mechanism of Action RANK ligand inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Osteoporosis
Most Recent Events
- 13 Mar 2003 No development reported - Preclinical for Osteoporosis in Japan (unspecified route)
- 02 Apr 2001 Preclinical development for Osteoporosis in Japan (unspecified route)